[go: up one dir, main page]

HN1997000071A - Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido - Google Patents

Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido

Info

Publication number
HN1997000071A
HN1997000071A HN1997000071A HN1997000071A HN1997000071A HN 1997000071 A HN1997000071 A HN 1997000071A HN 1997000071 A HN1997000071 A HN 1997000071A HN 1997000071 A HN1997000071 A HN 1997000071A HN 1997000071 A HN1997000071 A HN 1997000071A
Authority
HN
Honduras
Prior art keywords
fenetile
inhibition
substituted
compounds
metaloproteases
Prior art date
Application number
HN1997000071A
Other languages
English (en)
Original Assignee
Corporation Bayer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corporation Bayer filed Critical Corporation Bayer
Publication of HN1997000071A publication Critical patent/HN1997000071A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A INHIBICION DE LAS METALOPROTEASAS DE MATRIZ POR COMPUESTOS DE FENETILO SUSTITUIDO
HN1997000071A 1996-05-15 1997-05-12 Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido HN1997000071A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64502696A 1996-05-15 1996-05-15

Publications (1)

Publication Number Publication Date
HN1997000071A true HN1997000071A (es) 1997-06-18

Family

ID=24587359

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000071A HN1997000071A (es) 1996-05-15 1997-05-12 Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido

Country Status (24)

Country Link
EP (1) EP0907632B1 (es)
JP (1) JP3305328B2 (es)
CN (1) CN1124255C (es)
AR (1) AR007100A1 (es)
AT (1) ATE229497T1 (es)
AU (1) AU727899B2 (es)
BR (1) BR9709084A (es)
CA (1) CA2253870C (es)
CO (1) CO5070565A1 (es)
DE (1) DE69717811T2 (es)
DK (1) DK0907632T3 (es)
ES (1) ES2188943T3 (es)
HN (1) HN1997000071A (es)
HR (1) HRP970243B1 (es)
ID (1) ID17424A (es)
PA (1) PA8429801A1 (es)
PE (1) PE66298A1 (es)
PT (1) PT907632E (es)
SV (1) SV1997000037A (es)
TN (1) TNSN97082A1 (es)
TW (1) TW363056B (es)
WO (1) WO1997043247A1 (es)
YU (1) YU18497A (es)
ZA (1) ZA974029B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288063B1 (en) * 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
CA2356053A1 (en) 1998-12-30 2000-07-13 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
EP1031349A1 (en) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
FR2901320B1 (fr) * 2006-05-17 2008-07-04 Univ Savoie Etablissement Publ Dispositif miniaturise apte a fonctionner comme moteur ou refroidisseur selon un cycle thermodynamique de stirling
JP2017509665A (ja) 2014-04-03 2017-04-06 バイエル ファーマ アクチエンゲゼルシャフト 気道疾患治療のための２，５−ジ置換されたシクロペンタンカルボン酸類
US20170022171A1 (en) 2014-04-03 2017-01-26 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentanecarboxylic acids and their use
US20170119776A1 (en) 2014-04-03 2017-05-04 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2112716A1 (de) * 1971-03-17 1972-10-05 Thomae Gmbh Dr K Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
CO5011071A1 (es) 1996-05-15 2001-02-28 Bayer Corp Inhibicion de las metaloproteinasas de matriz por acidos 2-(w/aroilalquil)-4-biaril-4-oxobutiricos y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
TNSN97082A1 (fr) 2005-03-15
DE69717811T2 (de) 2003-05-28
WO1997043247A1 (en) 1997-11-20
ES2188943T3 (es) 2003-07-01
HRP970243B1 (en) 2002-06-30
ATE229497T1 (de) 2002-12-15
EP0907632A1 (en) 1999-04-14
CA2253870C (en) 2004-01-06
AR007100A1 (es) 1999-10-13
CO5070565A1 (es) 2001-08-28
TW363056B (en) 1999-07-01
ID17424A (id) 1997-12-24
PA8429801A1 (es) 2000-05-24
ZA974029B (en) 1998-02-19
AU727899B2 (en) 2001-01-04
YU18497A (en) 1999-11-22
HRP970243A2 (en) 1998-04-30
CN1124255C (zh) 2003-10-15
CN1225624A (zh) 1999-08-11
JP3305328B2 (ja) 2002-07-22
PE66298A1 (es) 1998-10-23
DE69717811D1 (en) 2003-01-23
EP0907632B1 (en) 2002-12-11
JPH11510517A (ja) 1999-09-14
CA2253870A1 (en) 1997-11-20
AU2938597A (en) 1997-12-05
DK0907632T3 (da) 2003-04-07
SV1997000037A (es) 1999-01-14
BR9709084A (pt) 1999-08-03
PT907632E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000023A (es) Derivados de lactama
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1998000036A (es) Compuesto de pirazina
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1999000089A (es) Formulaciones de ziprasidona
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000159A (es) Derivados de 9- amino - 3 ceto eritromicina
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
HN1997000079A (es) Analogos de indazol sustituido.
HN1997000099A (es) Inhibidores de metaloproteasas matriciales basados en
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998000175A (es) Imidazotriazininas
ES2162198T3 (es) Agentes estrogenos.
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000158A (es) Isoquinolinas
PT923530E (pt) Inibicao de metaloproteases de matriz por acidos biaril oxibutiricos substituidos
HN1997000071A (es) Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido
HN1998000199A (es) Agentes terapeuticos
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000165A (es) Polimorfos dofetilina
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
HN1997000066A (es) Inhibición de las metaloproteasas de matriz por acipos biariloxobutiricos sustituidos
HN1999000038A (es) Nuevos compuestos fungicidas